Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline

scientific article published on March 1999

Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3201/EID0502.990216
P932PMC publication ID2640692
P698PubMed publication ID10221884
P5875ResearchGate publication ID13076340

P50authorBruce M. PsatyQ30429993
Susan R HeckbertQ88077554
P2093author name stringSiscovick DS
Grayston JT
Jackson LA
Smith NL
P2860cites workRandomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study GroupQ37882250
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarctionQ37882420
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimenQ37882581
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.Q37886690
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart StudyQ37893723
The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal womenQ38510705
Alternative hypothesis for efficacy of macrolides in acute coronary syndromesQ43429541
P433issue2
P921main subjecterythromycinQ213511
doxycyclineQ422442
tetracyclineQ193045
myocardial infarctionQ12152
P304page(s)281-284
P577publication date1999-03-01
P1433published inEmerging Infectious DiseasesQ5235761
P1476titleLack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline
P478volume5

Reverse relations

cites work (P2860)
Q35917262Advances in the management of Chlamydia pneumoniae infections
Q35587190Antibiotic treatment of atherosclerosis
Q37873319Antibiotic use and risk of ischemic stroke in the elderly
Q37863427Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction
Q33935098Antibiotics in the prevention and treatment of coronary heart disease
Q33935003Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
Q51726841Chlamydia pneumoniae and Cardiovascular Disease.
Q33905858Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies
Q62279926Chlamydia pneumoniae and atherosclerotic cardiovascular disease
Q37876040Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study
Q37875263Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?
Q79299394Chronic infection and coronary artery disease
Q34514051Chronic infections and atherosclerosis/thrombosis
Q44772269Effect of tetracyclines on the development of vascular disease in veterans with acne or rosacea: a retrospective cohort study
Q33987842Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.
Q34562273Evidence for infectious agents in cardiovascular disease and atherosclerosis
Q43427569Genitourinary chlamydial infection: a reappraisal and hypothesis
Q33921219Infections and atherosclerosis
Q36342810Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.
Q37876321Past use of erythromycin, tetracycline, or doxycycline is not associated with risk of first myocardial infarction
Q38097947Periodontal disease and systemic illness: will the evidence ever be enough?
Q37872836Relation of antibiotic use to risk of myocardial infarction in the general population
Q34874476Role of antibiotics for the prevention of cardiovascular disease
Q34075142The association of infection and coronary artery disease: an update
Q33770472The possible role of infections in acute myocardial infarction

Search more.